- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01141348
The Weight-Wise Weight Loss Translation Study (Weight-Wise)
Intensive Behavioral Weight Management in Public Health Settings: Weight-Wise
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Low-income women in the US have the highest rates of overweight and obesity, putting them at increased risk for diabetes, heart disease, and other chronic illnesses. Because mean body mass index gradually increases during adult life and peaks at 50-59 years of age, low income women between 40-64 years are a group deserving of special attention. While there is sufficient evidence that some behavioral weight management interventions are effective in producing clinically meaningful levels of weight loss with reductions in cardiovascular risk factors and delayed onset of diabetes, there is a research gap in translating these efficacious interventions to real life settings and diverse population groups. Research that seeks to translate effective behavioral weight management interventions from resource-intensive efficacy trials to long-term adoption and implementation by public health settings serving a diverse low-income population is timely and of great public health significance. This translational research can provide important information to decision-makers about evidence-based intervention delivery, resource allocation, and workforce preparation.
The overall goal of the proposed research is to evaluate the processes and outcomes of translating from research to practice an intense, evidence-based behavioral weight loss intervention with demonstrated effectiveness among midlife low-income women. Originally studied in a single coordinated community health care center/church setting and delivered by research staff (Weight-Wise Pilot Study), we will evaluate the translation of and test the effectiveness of this intervention as implemented by existing staff in a range of county health departments supported by local community resources.
To evaluate the translation process, we will use the RE-AIM framework, diffusion of innovation theory, and systematic models of adaptation to assess: 1) factors related to reach; contextual or setting-specific factors necessary for successful adoption and implementation; 2) effectiveness of facilitator training and stakeholder collaborations; 3) adaptation and fidelity during implementation; and 4) costs associated with the implementation and outcomes. To test the intervention's effectiveness, we will enroll 240 overweight or obese low-income women, 40-64 years of age, at 6 representative public health agencies. Participants will be randomized to receive a 16-week behavioral weight loss intervention (special intervention group) or usual care (wait listed control group). The primary study outcome at 5 month follow-up is weight change; secondary outcomes include change in blood pressure, dietary intake, physical activity, and quality of life measures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Elizabeth City, North Carolina, United States, 27907
- Albemarle Regional Health Services
-
Lexington, North Carolina, United States, 27293
- Davidson County Health Department
-
Lincolnton, North Carolina, United States, 28092
- Lincoln County Health Department
-
Nashville, North Carolina, United States, 27856
- Nash County Health Department
-
Warrenton, North Carolina, United States, 27589
- Warren County Health Department
-
Winston-Salem, North Carolina, United States, 27102
- Forsyth County Health Department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI between 27.5 and 45
- willing to lose 5% or more of initial body weight and follow recommendations for healthy dietary and PA patterns
- English-speaking
- able and willing to give informed consent
- household income less than or equal to 250% of federal poverty guidelines.
Exclusion Criteria:
- medical or physical limitations to engaging in moderate level physical activity
- medical or other contraindications to weight loss
- history of gastric bypass surgery or scheduled surgery for this purpose
- weight loss of > 20 lbs in the last 3 months
- current use of medication for weight loss
- treatment of psychosis
- diagnosis of Type 1 diabetes.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Special Intervention
|
16 week behavioral weight loss intervention included 2 hour weekly group sessions
|
Experimental: Delayed Intervention
|
During the randomized controlled trial, the Delayed Intervention (DI) group received two newsletters with study updates and general health information.
Following the trial, the DI group received a 10-week weight loss program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Weight Change difference between baseline and 4 month follow-up
Time Frame: Baseline and 4 month follow-up
|
Baseline and 4 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in blood pressure, dietary intake, physical activity, and quality of life between baseline and 4 month follow-up
Time Frame: Baseline and 4 month follow-up
|
Baseline and 4 month follow-up
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Carmen Samuel-Hodge, PhD, MS, RD, University of North Carolina, Chapel Hill
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08-0055
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Special Intervention
-
San Diego State UniversityCompletedType 2 Diabetes Mellitus | Atherosclerosis | Hypercholesterolemia | Heart Disease | High Blood PressureUnited States
-
Guangdong Provincial People's HospitalRecruitingHypertension | Diabetes MellitusChina
-
Centre Hospitalier Intercommunal CreteilCompletedCOVID-19 | Pneumonia, ViralFrance
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompleted
-
Richard Solomon MD, PlcNational Institute of Mental Health (NIMH); Michigan State UniversityCompletedAutism Spectrum Disorder | AutismUnited States
-
Hopital Louis PradelCompletedCirculatory FailureFrance
-
Hopital Louis PradelCompletedCirculatory FailureFrance
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Terminated
-
Sun Yat-sen UniversityCompleted